After years known primarily as generic drug makers, Indian companies such as Dr. Reddy's and Ranbaxy Laboratories are joining the drug discovery and development race. They are banking on their tenacity and ability to quickly adapt to new markets to edge their way in among the more established pace setters. The new Indian drug discoverers will succeed or fail depending on how easily they, and the country's science community in general, can shift their mindsets and skill sets to discovering novel molecule. They will also have to be willing to take the risk and financial burden of bringing them to market. Dr. Reddy's Laboratories, is currently working to become the first Indian company to bring a new chemical entity to market.